Other
1 - 11 of
11 Results
Sort Results:
Article:
Xeljanz (ZEL-jans, tofacitinib), a new ORAL treatment for moderate to severe rheumatoid arthritis in adults
September 2014
Article:
Aggressive management of rheumatoid arthritis often means monitoring multiple meds
July 2012